Eli Lilly Corp. buy SVB Leerink LLC
Start price
10.11.25
/
50%
€807.50
Target price
10.11.26
€955.18
Performance (%)
-0.28%
Price
08.05.26
€805.20
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Eli Lilly Corp. is nearly unchanged. This prediction currently runs until 10.11.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 1.105% | 1.105% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $1,104.00 price target on the stock, up previously from $886.00.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€920.00
07.02.26
07.02.26
€1,097.5
07.02.27
07.02.27
-12.48%
08.05.26
08.05.26
